Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04743661Phase 2Active Not Recruiting
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Recurrent EpendymomaRecurrent Medulloblastoma
PrincipalinvestigatorStart date: 2022-04-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Donald W Parsons

Children's Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Andrea T Franson

Children's Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Meredith S Irwin

Children's Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Susan N Chi

Children's Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Elizabeth D Alva

Children's Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Soumen Khatua

M.D. Anderson Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Katherine A Janeway

Children's Oncology Group

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jeffrey M. Treiber, MD

The University of Texas Health Science Center, Houston

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma
Similarity Score30%

Theodore W Laetsch

Children's Oncology Group

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Christine A Pratilas

Children's Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04743661Phase 2PrincipalInvestigator

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Recurrent EpendymomaRecurrent Medulloblastoma
Active Not Recruiting

All 1 trials loaded